{"id":"43fc31df-b836-50a8-9d58-64e53e7e6f3c","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-the-puzzle-stated","predicate":"preserves_measured_pool","statement":"Acetaminophen has potent antipyretic and analgesic actions but very weak anti-inflammatory activity, and when administered to humans it reduces levels of prostaglandin metabolites in urine but does not reduce synthesis of prostaglandins by blood platelets or by the stomach mucosa; because it is a weak inhibitor in vitro of both cyclooxygenase-1 and -2 the possibility exists that it inhibits a so far unidentified form, and in animal studies cyclooxygenase in homogenates of different tissues varies in sensitivity to its inhibitory action, which may be evidence that there are more than two isoforms.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"neutral","is_public":true,"mechanism_event_id":"1df055cc-12db-5b73-8e8b-14e1528bbcfe","mechanism_event_label":"It lowers prostaglandins measured in urine while leaving the platelet and the stomach alone, and that is the puzzle every account has to solve.","subject":{"id":"a901be21-7915-543c-ac67-c39ef72b0d03","slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"},"object":{"id":"e63f771b-f8e3-50ac-91f1-ebf09af81259","slug":"platelet-thromboxane-production","display_name":"Platelet thromboxane A2 production in vitro","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"1df055cc-12db-5b73-8e8b-14e1528bbcfe","stable_key":"7de430a5-1a36-5231-b931-35cc01d8f3bf:apap-the-puzzle-stated-event","event_type":"observed_intervention","label":"It lowers prostaglandins measured in urine while leaving the platelet and the stomach alone, and that is the puzzle every account has to solve.","description":"Acetaminophen has potent antipyretic and analgesic actions but very weak anti-inflammatory activity, and when administered to humans it reduces levels of prostaglandin metabolites in urine but does not reduce synthesis of prostaglandins by blood platelets or by the stomach mucosa; because it is a weak inhibitor in vitro of both cyclooxygenase-1 and -2 the possibility exists that it inhibits a so far unidentified form, and in animal studies cyclooxygenase in homogenates of different tissues varies in sensitivity to its inhibitory action, which may be evidence that there are more than two isoforms.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"6284d26c-01e2-5e12-b192-ee391dd107e2","slug":"ptgs1","display_name":"Cyclooxygenase-1 (PTGS1)","entity_type_key":"protein"},"role":"weakly_inhibited_isoform","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"c8a31ed4-f2ca-5d43-8352-e9935129a785","slug":"ptgs2","display_name":"Cyclooxygenase-2 (PTGS2)","entity_type_key":"protein"},"role":"weakly_inhibited_isoform","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"a4c9b287-5373-57d2-b126-f1290d79343a","slug":"cox-3","display_name":"COX-3 / COX-1b, a cyclooxygenase-1 transcript retaining intron 1","entity_type_key":"protein"},"role":"hypothesised_alternative","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"168a23a4-0a61-5467-9f5f-75ebe322eeb3","slug":"cellular-selectivity","display_name":"Selectivity of a drug between cell types rather than between enzyme isoforms","entity_type_key":"cellular_process"},"role":"observed_pattern","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"a901be21-7915-543c-ac67-c39ef72b0d03","slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"e63f771b-f8e3-50ac-91f1-ebf09af81259","slug":"platelet-thromboxane-production","display_name":"Platelet thromboxane A2 production in vitro","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/paracetamol-research/11113024.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f3d9785240d2bc30e79775035576d3b017471500c110d627653e6fd80e820eee\", \"start_char\": 0, \"end_char\": 1012, \"text_sha256\": \"f3d9785240d2bc30e79775035576d3b017471500c110d627653e6fd80e820eee\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Review of the evidence for an unidentified cyclooxygenase form, written before COX-3 was cloned","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Acetaminophen compared against its effects on urinary prostaglandin metabolites and on platelet and gastric prostaglandin synthesis","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A review that states the puzzle precisely before an answer existed. The human observations it collects are the clinical signature any mechanism has to explain.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.","comparator":null,"unit":null,"notes":"","entity":{"slug":"acetaminophen","display_name":"Paracetamol","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human and animal","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"It lowers prostaglandins measured in urine while leaving the platelet and the stomach alone, and that is the puzzle every account has to solve.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[apap-p11113024] Mechanism of action of acetaminophen: is there a cyclooxygenase 3? (2000). https://pubmed.ncbi.nlm.nih.gov/11113024/ DOI: 10.1086/317520","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Platelets, gastric mucosa and tissue homogenates","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"c8f2bfe1-b9ae-5728-abee-4ff0be1c2a98","evidence_kind":"source_excerpt","locator":"Lines 207-218","start_line":207,"end_line":218,"excerpt":"### apap-the-puzzle-stated\nAcetaminophen has potent antipyretic and analgesic actions but very weak anti-inflammatory activity, and when administered to humans it reduces levels of prostaglandin metabolites in urine but does not reduce synthesis of prostaglandins by blood platelets or by the stomach mucosa; because it is a weak inhibitor in vitro of both cyclooxygenase-1 and -2 the possibility exists that it inhibits a so far unidentified form, and in animal studies cyclooxygenase in homogenates of different tissues varies in sensitivity to its inhibitory action, which may be evidence that there are more than two isoforms.\nCondition category: normal\nnutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404.\nplain_language: It lowers prostaglandins measured in urine while leaving the platelet and the stomach alone, and that is the puzzle every account has to solve.\norganism: Human and animal\ntissue_or_cell_type: Platelets, gastric mucosa and tissue homogenates\nexperimental_model: Review of the evidence for an unidentified cyclooxygenase form, written before COX-3 was cloned\nlimitations: A review that states the puzzle precisely before an answer existed. The human observations it collects are the clinical signature any mechanism has to explain.\nexposure: Acetaminophen compared against its effects on urinary prostaglandin metabolites and on platelet and gastric prostaglandin synthesis\nevidence_span: {\"source_cache\": \"artifacts/paracetamol-research/11113024.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f3d9785240d2bc30e79775035576d3b017471500c110d627653e6fd80e820eee\", \"start_char\": 0, \"end_char\": 1012, \"text_sha256\": \"f3d9785240d2bc30e79775035576d3b017471500c110d627653e6fd80e820eee\"}\n[apap-p11113024] Mechanism of action of acetaminophen: is there a cyclooxygenase 3? (2000). https://pubmed.ncbi.nlm.nih.gov/11113024/ DOI: 10.1086/317520","model_system":"Review of the evidence for an unidentified cyclooxygenase form, written before COX-3 was cloned","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [apap-p11113024] Mechanism of action of acetaminophen: is there a cyclooxygenase 3? (2000). https://pubmed.ncbi.nlm.nih.gov/11113024/ DOI: 10.1086/317520","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"9ee11177-f860-5877-bb82-f4ee4acdc538","stable_key":"import-7de430a5-1a36-5231-b931-35cc01d8f3bf","title":"Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"9c145887aa10fa7b85f54712e0b41fd9e04fb9544d3182793dd84414dbf8c2ae","revision_id":"c3e7827a-4f10-55e0-97b9-5782b044f7cc","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}